Deutsch
 
Mein Konto  

ANMELDEN & VORTEILE SICHERN

  • Preise & Rabatte einsehen
  • Geschenke sichern
  • Angebote anfragen & online annehmen
JETZT ANMELDEN Noch nicht registriert? Konto hier erstellen!
Vergleich
Ergebnisse

Ergebnisse filtern

Typ
Specific against
Host
Applications
Isotype
Hersteller

Inhibitors & Compound Libraries

609594 Artikel

pro Seite

Seite:
  1. 94
  2. 95
  3. 96
  4. 97
  5. 98
Name PDF Typ Clone Specific against Appl. Host ArtNr. Menge ✓ Preis
Sulfaproxyline Inhibitors Other Sulfaproxyline is antibiotics. DCC-DC60069-1g

DCChemicals 		1 g Anmelden
Vergleichen
MM-­102 TFA Inhibitors Other DCC-DC60072-100mg

DCChemicals 		100 mg Anmelden
Vergleichen
MM-­102 TFA Inhibitors Other DCC-DC60072-250mg

DCChemicals 		250 mg Anmelden
Vergleichen
MM-­102 TFA Inhibitors Other DCC-DC60072-1g

DCChemicals 		1 g Anmelden
Vergleichen
Rineterkib(ERK-­IN-­1;compound B) Inhibitors Other Rineterkib, also known as LTT-462 or ERK-IN-1, is a RAF and ERK1/2 inhibitor which has demonstrated preclinical activity in multiple MAPK activated cancer cells and xenograft models. LTT462 binds to and inhibits ERK, thereby preventing the activation of ERK-mediated signal transduction pathways. This results in the inhibition of ERK-dependent tumor cell proliferation and survival. The mitogen-activated protein kinase (MAPK)/ERK pathway is upregulated in numerous tumor, differentiation and survival. DCC-DC57035-25mg

DCChemicals 		25 mg Anmelden
Vergleichen
GUN30820 Inhibitors Other DCC-DC60089-1g

DCChemicals 		1 g Anmelden
Vergleichen
GUN30820 Inhibitors Other DCC-DC60089-250mg

DCChemicals 		250 mg Anmelden
Vergleichen
GUN30820 Inhibitors Other DCC-DC60089-100mg

DCChemicals 		100 mg Anmelden
Vergleichen
Ozanimod hydrochloride Inhibitors Other respectively., Ozanimod is a potent and selective S1P1 and S1P5 receptor agonist with EC50s of 410±160 pM and 11±4.3 nM in [35S]-GTPγS binding DCC-DC59005-100mg

DCChemicals 		100 mg Anmelden
Vergleichen
Ozanimod hydrochloride Inhibitors Other respectively., Ozanimod is a potent and selective S1P1 and S1P5 receptor agonist with EC50s of 410±160 pM and 11±4.3 nM in [35S]-GTPγS binding DCC-DC59005-250mg

DCChemicals 		250 mg Anmelden
Vergleichen
Ozanimod hydrochloride Inhibitors Other respectively., Ozanimod is a potent and selective S1P1 and S1P5 receptor agonist with EC50s of 410±160 pM and 11±4.3 nM in [35S]-GTPγS binding DCC-DC59005-1g

DCChemicals 		1 g Anmelden
Vergleichen
XEN723 Inhibitors Other IC DCC-DC57080-100mg

DCChemicals 		100 mg Anmelden
Vergleichen
XEN723 Inhibitors Other IC DCC-DC57080-250mg

DCChemicals 		250 mg Anmelden
Vergleichen
XEN723 Inhibitors Other IC DCC-DC57080-1g

DCChemicals 		1 g Anmelden
Vergleichen
FIDAS-­3 Inhibitors Other IC DCC-DC57081-100mg

DCChemicals 		100 mg Anmelden
Vergleichen
FIDAS-­3 Inhibitors Other IC DCC-DC57081-250mg

DCChemicals 		250 mg Anmelden
Vergleichen
FIDAS-­3 Inhibitors Other IC DCC-DC57081-1g

DCChemicals 		1 g Anmelden
Vergleichen
MC-­MMAE Inhibitors Other ELISA DCC-DC57082-100mg

DCChemicals 		100 mg Anmelden
Vergleichen
SU0268 Inhibitors Other SU0268 is a potent and selective OGG1 inhibitor. DNA glycosylases involved in the first step of the DNA base excision repair pathway are promising targets in cancer therapy. There is evidence that reduction of their activities may enhance cell killing in DCC-DC57088-100mg

DCChemicals 		100 mg Anmelden
Vergleichen
SU0268 Inhibitors Other SU0268 is a potent and selective OGG1 inhibitor. DNA glycosylases involved in the first step of the DNA base excision repair pathway are promising targets in cancer therapy. There is evidence that reduction of their activities may enhance cell killing in DCC-DC57088-250mg

DCChemicals 		250 mg Anmelden
Vergleichen
SU0268 Inhibitors Other SU0268 is a potent and selective OGG1 inhibitor. DNA glycosylases involved in the first step of the DNA base excision repair pathway are promising targets in cancer therapy. There is evidence that reduction of their activities may enhance cell killing in DCC-DC57088-1g

DCChemicals 		1 g Anmelden
Vergleichen
MAT2A inhibitor-­2 Inhibitors Other MAT2A inhibitor 2 is a methionine adenosyltransferase 2A (MAT2A) inhibitor. DCC-DC57110-100mg

DCChemicals 		100 mg Anmelden
Vergleichen
MAT2A inhibitor-­2 Inhibitors Other MAT2A inhibitor 2 is a methionine adenosyltransferase 2A (MAT2A) inhibitor. DCC-DC57110-250mg

DCChemicals 		250 mg Anmelden
Vergleichen
5-­ethyl-­4-­methyl-­N-­{4-­[(2S)-­morpholin-­2-­yl]phenyl}-­1Hpyrazole-­3-­carboxamide hydrochloride Inhibitors Other Ralmitaront, also known as WHO 11130, RO 6889450 and RG7906, is a neuroleptic. DCC-DC60049-100mg

DCChemicals 		100 mg Anmelden
Vergleichen
5-­ethyl-­4-­methyl-­N-­{4-­[(2S)-­morpholin-­2-­yl]phenyl}-­1Hpyrazole-­3-­carboxamide hydrochloride Inhibitors Other Ralmitaront, also known as WHO 11130, RO 6889450 and RG7906, is a neuroleptic. DCC-DC60049-250mg

DCChemicals 		250 mg Anmelden
Vergleichen
Name Preis
Sulfaproxyline Anmelden Sulfaproxyline
Typ Inhibitors
Clone
Specific against Other
Appl. Sulfaproxyline is antibiotics.
Host
ArtNr.
Menge 1 g
Lieferbar
MM-­102 TFA Anmelden MM-102 TFA
Typ Inhibitors
Clone
Specific against Other
Appl.
Host
ArtNr.
Menge 100 mg
Lieferbar
MM-­102 TFA Anmelden MM-102 TFA
Typ Inhibitors
Clone
Specific against Other
Appl.
Host
ArtNr.
Menge 250 mg
Lieferbar
MM-­102 TFA Anmelden MM-102 TFA
Typ Inhibitors
Clone
Specific against Other
Appl.
Host
ArtNr.
Menge 1 g
Lieferbar
Rineterkib(ERK-­IN-­1;compound B) Anmelden Rineterkib(ERK-IN-1;compound B)
Typ Inhibitors
Clone
Specific against Other
Appl. Rineterkib, also known as LTT-462 or ERK-IN-1, is a RAF and ERK1/2 inhibitor which has demonstrated preclinical activity in multiple MAPK activated cancer cells and xenograft models. LTT462 binds to and inhibits ERK, thereby preventing the activation of ERK-mediated signal transduction pathways. This results in the inhibition of ERK-dependent tumor cell proliferation and survival. The mitogen-activated protein kinase (MAPK)/ERK pathway is upregulated in numerous tumor, differentiation and survival.
Host
ArtNr.
Menge 25 mg
Lieferbar
GUN30820 Anmelden GUN30820
Typ Inhibitors
Clone
Specific against Other
Appl.
Host
ArtNr.
Menge 1 g
Lieferbar
GUN30820 Anmelden GUN30820
Typ Inhibitors
Clone
Specific against Other
Appl.
Host
ArtNr.
Menge 250 mg
Lieferbar
GUN30820 Anmelden GUN30820
Typ Inhibitors
Clone
Specific against Other
Appl.
Host
ArtNr.
Menge 100 mg
Lieferbar
Ozanimod hydrochloride Anmelden Ozanimod hydrochloride
Typ Inhibitors
Clone
Specific against Other
Appl. respectively., Ozanimod is a potent and selective S1P1 and S1P5 receptor agonist with EC50s of 410±160 pM and 11±4.3 nM in [35S]-GTPγS binding
Host
ArtNr.
Menge 100 mg
Lieferbar
Ozanimod hydrochloride Anmelden Ozanimod hydrochloride
Typ Inhibitors
Clone
Specific against Other
Appl. respectively., Ozanimod is a potent and selective S1P1 and S1P5 receptor agonist with EC50s of 410±160 pM and 11±4.3 nM in [35S]-GTPγS binding
Host
ArtNr.
Menge 250 mg
Lieferbar
Ozanimod hydrochloride Anmelden Ozanimod hydrochloride
Typ Inhibitors
Clone
Specific against Other
Appl. respectively., Ozanimod is a potent and selective S1P1 and S1P5 receptor agonist with EC50s of 410±160 pM and 11±4.3 nM in [35S]-GTPγS binding
Host
ArtNr.
Menge 1 g
Lieferbar
XEN723 Anmelden XEN723
Typ Inhibitors
Clone
Specific against Other
Appl. IC
Host
ArtNr.
Menge 100 mg
Lieferbar
XEN723 Anmelden XEN723
Typ Inhibitors
Clone
Specific against Other
Appl. IC
Host
ArtNr.
Menge 250 mg
Lieferbar
XEN723 Anmelden XEN723
Typ Inhibitors
Clone
Specific against Other
Appl. IC
Host
ArtNr.
Menge 1 g
Lieferbar
FIDAS-­3 Anmelden FIDAS-3
Typ Inhibitors
Clone
Specific against Other
Appl. IC
Host
ArtNr.
Menge 100 mg
Lieferbar
FIDAS-­3 Anmelden FIDAS-3
Typ Inhibitors
Clone
Specific against Other
Appl. IC
Host
ArtNr.
Menge 250 mg
Lieferbar
FIDAS-­3 Anmelden FIDAS-3
Typ Inhibitors
Clone
Specific against Other
Appl. IC
Host
ArtNr.
Menge 1 g
Lieferbar
MC-­MMAE Anmelden MC-MMAE
Typ Inhibitors
Clone
Specific against Other
Appl. ELISA
Host
ArtNr.
Menge 100 mg
Lieferbar
SU0268 Anmelden SU0268
Typ Inhibitors
Clone
Specific against Other
Appl. SU0268 is a potent and selective OGG1 inhibitor. DNA glycosylases involved in the first step of the DNA base excision repair pathway are promising targets in cancer therapy. There is evidence that reduction of their activities may enhance cell killing in
Host
ArtNr.
Menge 100 mg
Lieferbar
SU0268 Anmelden SU0268
Typ Inhibitors
Clone
Specific against Other
Appl. SU0268 is a potent and selective OGG1 inhibitor. DNA glycosylases involved in the first step of the DNA base excision repair pathway are promising targets in cancer therapy. There is evidence that reduction of their activities may enhance cell killing in
Host
ArtNr.
Menge 250 mg
Lieferbar
SU0268 Anmelden SU0268
Typ Inhibitors
Clone
Specific against Other
Appl. SU0268 is a potent and selective OGG1 inhibitor. DNA glycosylases involved in the first step of the DNA base excision repair pathway are promising targets in cancer therapy. There is evidence that reduction of their activities may enhance cell killing in
Host
ArtNr.
Menge 1 g
Lieferbar
MAT2A inhibitor-­2 Anmelden MAT2A inhibitor-2
Typ Inhibitors
Clone
Specific against Other
Appl. MAT2A inhibitor 2 is a methionine adenosyltransferase 2A (MAT2A) inhibitor.
Host
ArtNr.
Menge 100 mg
Lieferbar
MAT2A inhibitor-­2 Anmelden MAT2A inhibitor-2
Typ Inhibitors
Clone
Specific against Other
Appl. MAT2A inhibitor 2 is a methionine adenosyltransferase 2A (MAT2A) inhibitor.
Host
ArtNr.
Menge 250 mg
Lieferbar
5-­ethyl-­4-­methyl-­N-­{4-­[(2S)-­morpholin-­2-­yl]phenyl}-­1Hpyrazole-­3-­carboxamide hydrochloride Anmelden 5-ethyl-4-methyl-N-{4-[(2S)-morpholin-2-yl]phenyl}-1Hpyrazole-3-carboxamide hydrochloride
Typ Inhibitors
Clone
Specific against Other
Appl. Ralmitaront, also known as WHO 11130, RO 6889450 and RG7906, is a neuroleptic.
Host
ArtNr.
Menge 100 mg
Lieferbar
5-­ethyl-­4-­methyl-­N-­{4-­[(2S)-­morpholin-­2-­yl]phenyl}-­1Hpyrazole-­3-­carboxamide hydrochloride Anmelden 5-ethyl-4-methyl-N-{4-[(2S)-morpholin-2-yl]phenyl}-1Hpyrazole-3-carboxamide hydrochloride
Typ Inhibitors
Clone
Specific against Other
Appl. Ralmitaront, also known as WHO 11130, RO 6889450 and RG7906, is a neuroleptic.
Host
ArtNr.
Menge 250 mg
Lieferbar

609594 Artikel

pro Seite

Seite:
  1. 94
  2. 95
  3. 96
  4. 97
  5. 98
Kontakt

Hölzel Diagnostika Handels GmbH
Weinsbergstr 118a
D-50823 Köln

T +49 221 126 02 66
F +49 221 126 02 67

info@hoelzel.de

Über Hölzel
Service
Infothek
Spendenaktion Datenschutzsiegel

Copyright 2025 Hölzel Diagnostika Handels GmbH

To top